Conceptio
›
Archive
›
ClinicalTrials.gov
ClinicalTrials.gov
public full text
Elotuzumab, CC-92480, and Dexamethasone for the Treatment of Relapsed or Refractory Myeloma After CD38- and BCMA-Targeted Therapies
Abdullah Khan
· 2023
ClinicalTrials.gov · Datasets · License: Public Domain · 2023
Open Source ↗
recurrent multiple myeloma, refractory multiple myeloma, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Imaging Procedure Using ALA in Finding Residual Tumor in Grade IV Malignant Astrocytoma
#1033716
Acupuncture for Heel Pain Syndrome
#1033717
A Study to Assess Safety and Efficacy of Vilaprisan in Subjects With Uterine Fibroids
#1033719
Results of Endoscopic Sinus Surgery in Management of Ophthalmological Complications of Chronic Rhino Sinusitis
#1033721
Infusional Carfilzomib in Patients With Relapsed or Refractory Multiple Myeloma
#1033723
Record
· ID 810799
Retrieved via
Conceptio
— every document is proof-bundled with source, license, and retrieval metadata.